Total Payments
$16,825
2024 Payments
$3,670
Companies
41
Transactions
665
Medicare Patients
12,117
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$16,805 (99.9%)
Education$20.17 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,805 | 662 | 99.9% |
| Education | $20.17 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,057 | 35 | $0 (2024) |
| Amgen Inc. | $1,992 | 104 | $0 (2024) |
| Abbott Laboratories | $1,875 | 59 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,486 | 84 | $0 (2024) |
| PFIZER INC. | $1,156 | 55 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $940.95 | 36 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $722.64 | 61 | $0 (2024) |
| Inari Medical, Inc. | $652.35 | 7 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $623.35 | 31 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $465.49 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,670 | 134 | Edwards Lifesciences Corporation ($573.69) |
| 2023 | $2,229 | 92 | Novartis Pharmaceuticals Corporation ($390.05) |
| 2022 | $1,859 | 75 | Abbott Laboratories ($371.58) |
| 2021 | $1,556 | 73 | Abbott Laboratories ($362.95) |
| 2020 | $883.96 | 50 | Amgen Inc. ($265.37) |
| 2019 | $2,362 | 88 | Amgen Inc. ($784.45) |
| 2018 | $2,588 | 86 | Abbott Laboratories ($604.28) |
| 2017 | $1,676 | 67 | Medtronic Vascular, Inc. ($363.60) |
All Payment Transactions
665 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Medtronic, Inc. | AZURE XT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Pacemakers | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $34.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/17/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Transcatheter Heart Valves | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: DIABETES | ||||||
| 12/06/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.40 | General |
| Category: Cardiovascular | ||||||
| 11/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: DIABETES | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $1.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/15/2024 | Edwards Lifesciences Corporation | KONECT RESILIA (Device) | Food and Beverage | In-kind items and services | $139.16 | General |
| Category: Pericardial Heart Valves | ||||||
| 11/15/2024 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: EMBLEM_CRM | ||||||
| 11/13/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 11/07/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: DEVICES | ||||||
| 11/06/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $29.09 | General |
| 11/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.39 | General |
| 10/30/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Heart Failure | ||||||
| 10/29/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $16.38 | General |
| Category: Coronary | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.76 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.64 | General |
| Category: Cardiovascular | ||||||
| 10/18/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $153.83 | General |
| Category: VTE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 3,642 | 6,004 | $2.0M | $544,797 |
| 2022 | 27 | 3,578 | 5,630 | $1.7M | $501,997 |
| 2021 | 28 | 2,602 | 4,454 | $1.4M | $412,064 |
| 2020 | 23 | 2,295 | 3,491 | $1.1M | $288,903 |
Total Patients
12,117
Total Services
19,579
Medicare Billing
$1.7M
Procedure Codes
109
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 656 | 1,026 | $212,286 | $105,401 | 49.7% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 112 | 113 | $165,681 | $89,993 | 54.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 378 | 414 | $589,950 | $70,360 | 11.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 208 | 677 | $152,325 | $68,838 | 45.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 125 | 770 | $115,500 | $34,696 | 30.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 115 | 754 | $135,720 | $31,543 | 23.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 168 | 193 | $77,200 | $28,563 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 175 | 175 | $56,875 | $23,104 | 40.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 372 | 391 | $205,275 | $22,671 | 11.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 78 | 102 | $29,478 | $15,274 | 51.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 103 | 115 | $16,863 | $8,395 | 49.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 22 | 44 | $26,400 | $7,952 | 30.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 442 | 470 | $51,700 | $5,645 | 10.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 77 | $11,319 | $5,308 | 46.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $9,150 | $4,438 | 48.5% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 24 | 25 | $33,125 | $4,103 | 12.4% |
| 93226 | Electrocardiogram (ecg) 2-day continuous with report | Office | 2023 | 112 | 113 | $20,800 | $3,809 | 18.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 56 | $9,800 | $3,796 | 38.7% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 17 | 17 | $22,525 | $3,442 | 15.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 224 | 272 | $27,200 | $1,879 | 6.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $5,500 | $1,744 | 31.7% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 17 | 17 | $5,525 | $797.47 | 14.4% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 43 | 44 | $2,860 | $687.42 | 24.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 13 | 13 | $1,196 | $653.38 | 54.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 11 | 11 | $1,530 | $586.40 | 38.3% |
About Dr. Andreas Mauer, M.D
Dr. Andreas Mauer, M.D is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1477739597.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andreas Mauer, M.D has received a total of $16,825 in payments from pharmaceutical and medical device companies, with $3,670 received in 2024. These payments were reported across 665 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($16,805).
As a Medicare-enrolled provider, Mauer has provided services to 12,117 Medicare beneficiaries, totaling 19,579 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Pasadena, CA
- Active Since 01/18/2008
- Last Updated 07/16/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1477739597
Products in Payments
- Repatha (Biological) $1,426
- ELIQUIS (Drug) $1,363
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $949.02
- ENTRESTO (Drug) $883.74
- FLOWTRIEVER CATHETER, S (Device) $652.35
- SAPIEN 3 Ultra RESILIA (Device) $627.25
- LifeVest (Device) $623.35
- LEQVIO (Drug) $602.30
- Corlanor (Drug) $566.14
- BRILINTA (Drug) $538.71
- CardioMEMS HF System (Device) $476.12
- XARELTO (Drug) $465.49
- VYNDAQEL (Drug) $363.91
- VERQUVO (Drug) $361.67
- CoreValve Evolut (Device) $348.06
- JARDIANCE (Drug) $302.80
- Impella (Device) $300.28
- Coronary Orbital Atherectomy System (Device) $294.47
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $291.03
- FARXIGA (Drug) $270.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Internal Medicine $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Internal Medicine $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Internal Medicine $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Internal Medicine $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Internal Medicine $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882
Internal Medicine $61,882